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Introduction
Primary non-urothelial bladder tumors are uncommon
and account for less than 1% of all bladder cancers.1
Among these tumors, extraosseous osteoclast-like giant
cell (OGC) tumors are extremely rare and have mainly
been found in the liver, breast, gallbladder and pan-
creas.2 Fewer than 10 cases of this type of carcinoma
have been reported in the urinary tract.3,4 The most
common symptom of these tumors, which present as
transitional cell carcinomas, is painless gross hematuria.
On pathology, OGC neoplasms of the urinary tract are
composed of ovoid or spindle-shaped mononuclear
cells with evenly spaced OGCs, and stain positively for
CD68 and vimentin immunohistochemically. Here, we
report a case of OGC carcinoma of the urinary bladder
with right ureter invasion.
Case Report
A 62-year-old man, who had no history of systemic
disease, had suffered from painless gross hematuria for
about 3 months. Intravenous pyelography disclosed
no filling defect lesion of the urinary tract. Urine
cytology revealed no malignancy. Cystoscopy revealed
a tumor over the right lateral wall of the urinary blad-
der. Transurethral tumor resection was performed, and
pathology led to the suspicion of OGC carcinoma.
Abdominal computed tomography showed irregular
right lateral wall thickness of the urinary bladder with
right distal ureter partial obstruction (Figure 1). Other
images showed no obvious metastasis over the lymph
nodes, liver or lungs.
The patient received radical cystoprostatectomy
with partial ureterectomy and transureteroureteros-
tomy. Pathology showed OGC undifferentiated carci-
noma with marked tumor necrosis (Figure 2) and
invasion of the deep muscular layer of the urinary
bladder and right distal ureter. The pathologic stage
of the disease was stage II (T2bN0M0), without
metastasis or angiolymphatic permeation. Immuno-
histochemical stains were positive for CD68 (Figure 3)
and vimentin. The pathological finding was focally
positive for factor VIII, CD31 and S-100, and nega-
tive for AE1/AE3 (triple), CK7 (twice), CK20 (twice),
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epithelial membrane antigen, chromogranin-A, synap-
tophysin, actin M851, actin M874 and leukocyte com-
mon antigen.
Ten days after the operation, the patient was dis-
charged in a stable condition. At the 5-month follow-
up, there was no local recurrence or distant metastasis.
Discussion
Over 90% of bladder tumors originate from the epi-
thelium of the urinary tract. Non-urothelial tumors
include squamous cell carcinoma (5%), adenocarci-
noma (2%) and anaplastic carcinoma.1 Extraosseous
OGC carcinoma of the urinary tract is extremely rare
and has most frequently been reported in the breast
and pancreas. To the best of our knowledge, fewer
than 10 cases of OGC carcinoma of the urinary tract
have been reported in the literature.3,4 There has
been much controversy regarding the nature and ori-
gin of epithelial, histiocytic, and mesenchymal OGCs.
One study indicated that these types of OGCs may
result from the fusion of mononuclear histiocytes/
macrophages attracted to the tumor by growth or
chemotactic factors elaborated by neoplastic epithelial
cells.5 On immunohistochemical analysis in this study,
OGCs were positive for vimentin and cell surface pro-
teins CD68 and CD45, and negative for cytokeratin
and epithelial membrane antigen.6 In our case, the
pathological finding was focally positive for factor
VIII, CD31 and S-100, and positive for vimentin and
CD68. These focally positive reactions may be associ-
ated with lesions or prognosis of OGC carcinoma.
However, further investigation is needed for a better
understanding of this phenomenon.
The symptoms of extraosseous OGC carcinoma in
the urinary tract are nonspecific. As is well-known,
hematuria is the most common and frequent initial
symptom.7 The appearance of OGC carcinoma under
cystoureteroscopy is similar to that of other uroepithe-
lial tumors. Such tumors like nephrogenic adenoma
of the urinary bladder can only be differentiated by
pathological characteristics.8 Because of the rarity of
OGC tumors of the urinary tract, the prognosis is
controversial. According to previous reports, the me-
dian survival is less than 2 years.4 Surgery is the best
choice of treatment. Aggressive management is rec-
ommended due to poor prognosis, but no adjuvant
treatment has yet been established. Adjuvant radiation
therapy may be beneficial, as giant cell tumor of the
bone is radiosensitive. Although adjuvant chemother-
apy such as MEC (mitoxantrone, etoposide and cyclo-
sporin) has been reported to be beneficial in patients
with transitional cell carcinoma of the urinary tract, 
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Figure 1. Abdominal computed tomography shows irregular right
lateral wall thickness of the urinary bladder with right distal ureter
obstruction.
Figure 3. Osteoclast-like giant cell undifferentiated carcinoma
(arrow) was positive for CD68 (original magnification, 100×).
Figure 2. Pathology shows osteoclast-like giant cell undifferenti-
ated carcinoma (arrow) (hematoxylin & eosin; original magnifica-
tion, 100×).
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a large population-based study is needed to confirm the
benefits of such therapy in the treatment of invasive
OGC tumors of the urinary tract.6 According to past
reports, extensive surgical excision appears to be the
common consensus for primary or recurrent lesions
until the treatment benefits of adjuvant chemotherapy
or radiotherapy can be established.4
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